We are live on ! Find out more
DMK

David M. Knott Portfolio holdings

AUM $275M
1-Year Est. Return 59.23%
This Fund
S&P 500
This Quarter Est. Return
-1.61%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
–
AUM
$237M
AUM Growth
-$13.8M
Cap. Flow
-$6.52M
Cap. Flow %
-2.75%
Top 10 Hldgs %
59.31%
Holding
121
New
11
Increased
20
Reduced
8
Closed
10

Top Buys

Rank Stock Value
1
BRSL
Brightstar Lottery PLC
BRSL
+$6.7M
2
SRCL
Stericycle Inc
SRCL
+$2.29M
3
FTAI icon
FTAI Aviation
FTAI
+$1.97M
4
CLMT icon
Calumet Specialty Products
CLMT
+$1.49M
5
LGND icon
Ligand Pharmaceuticals
LGND
+$1.06M

Top Sells

Rank Stock Value
1
CFFN icon
Capitol Federal Financial
CFFN
+$8.97M
2
ORCL icon
Oracle
ORCL
+$8.06M
3
IRDM icon
Iridium Communications
IRDM
+$3M
4
CXW icon
CoreCivic
CXW
+$1.46M
5
ZGNX
Zogenix, Inc.
ZGNX
+$1.43M

Sector Composition

Rank Sector Weight
1 Healthcare 32.15%
2 Industrials 13.86%
3 Technology 10.97%
4 Consumer Discretionary 9.86%
5 Energy 8.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STWD icon
101
Starwood Property Trust
STWD
$5.85B
$9K ﹤0.01%
400
– –
DBRG icon
102
DigitalBridge
DBRG
$2.99B
$7K ﹤0.01%
367
– –
AMLP icon
103
Alerian MLP ETF
AMLP
$13.4B
$6K ﹤0.01%
120
– –
MBAI
104
Check-Cap
MBAI
$9.05M
$5K ﹤0.01%
16
– –
SCU
105
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$5K ﹤0.01%
200
– –
RMR icon
106
The RMR Group
RMR
$332M
$1K ﹤0.01%
16
– –
WAB icon
107
Wabtec
WAB
$49.4B
$1K ﹤0.01%
23
– –
AFMD
108
DELISTED
Affimed
AFMD
– –
-1,604
Closed -$67K
ALNY icon
109
Alnylam Pharmaceuticals
ALNY
$31.7B
– –
-500
Closed -$47K
BIIB icon
110
Biogen
BIIB
$32.3B
– –
-2,498
Closed -$590K
CXW icon
111
CoreCivic
CXW
$3.34B
– –
-75,000
Closed -$1.46M
IRDM icon
112
Iridium Communications
IRDM
$4.94B
– –
-113,399
Closed -$3M
ORCL icon
113
Oracle
ORCL
$435B
– –
-150,000
Closed -$8.06M
TVRD
114
Tvardi Therapeutics
TVRD
$24.3M
– –
-198
Closed -$140K
NUVA
115
DELISTED
NuVasive, Inc.
NUVA
– –
-2,000
Closed -$114K
CNCE
116
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
– –
-83,607
Closed -$1.01M
ZGNX
117
DELISTED
Zogenix, Inc.
ZGNX
– –
-26,039
Closed -$1.43M
1 2 3 4
5

Similar funds

FA
FMA Advisory Harrisburg, Pennsylvania $268M AUM 30.8% 1-Year Est. Return
KCP
KDI Capital Partners Raleigh, North Carolina $290M AUM 26.07% 1-Year Est. Return
HCIA
Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return
ISG
Investment Security Group Denver, Colorado $252M AUM 28.26% 1-Year Est. Return
TPCM
Three Peaks Capital Management Castle Rock, Colorado $301M AUM 43.39% 1-Year Est. Return
DCM
DeGreen Capital Management Scottsdale, Arizona $301M AUM 17.24% 1-Year Est. Return
MCL
MIK Capital LP New York $247M AUM 78.02% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return

David M. Knott's Q2 2019 Portfolio in Review

As of Q2 2019, David M. Knott held 121 positions worth $237M, down 5.5% from $251M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

David M. Knott's Q2 2019 filing shows 11 new, 20 increased, 8 reduced and 10 closed positions. Its largest new stake was FEDERAL NATL MTG ASS 08250: 85,000 shares worth $996K. The largest sale was Capitol Federal Financial, an estimated $8.97M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Industrials and Technology.

  • David M. Knott's largest Q2 2019 buy was FEDERAL NATL MTG ASS 08250: 85,000 shares worth $996K.
  • David M. Knott added most to Brightstar Lottery PLC in Q2 2019, an estimated $6.7M increase.
  • David M. Knott's biggest Q2 2019 reduction was Capitol Federal Financial, cutting an estimated $8.97M.
  • David M. Knott fully exited Oracle in Q2 2019, selling an estimated $8.06M.
  • David M. Knott's ten largest holdings make up 59% of its $237M portfolio in Q2 2019.
  • David M. Knott opened 11 new positions and closed 10 in Q2 2019.
  • David M. Knott's portfolio value fell 5.5% quarter-over-quarter to $237M.

Based on David M. Knott's 13F filing for Q2 2019, filed 12 Aug 2019.